Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies. Its mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development. 

Type
Private
HQ
Huntington, US
Founded
2014
Size (employees)
12 (est)
Envisagenics was founded in 2014 and is headquartered in Huntington, US
Report incorrect company information

Envisagenics Office Locations

Envisagenics has an office in Huntington
Show all (1)
Report incorrect company information

Envisagenics Financials and Metrics

Summary Metrics

Envisagenics's latest funding round in November 2017 was reported to be $2.4 m. In total, Envisagenics has raised $3.1 m
Show all financial metrics
Report incorrect company information